Sargent Bickham Lagudis’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $17K | Hold |
220
| – | – | ﹤0.01% | 638 |
|
|
2022
Q3 | $10K | Hold |
220
| – | – | ﹤0.01% | 685 |
|
|
2022
Q2 | $8K | Hold |
220
| – | – | ﹤0.01% | 722 |
|
|
2022
Q1 | $9K | Hold |
220
| – | – | ﹤0.01% | 720 |
|
|
2021
Q4 | $8K | Hold |
220
| – | – | ﹤0.01% | 736 |
|
|
2021
Q3 | $7K | Sell |
220
-145
| -40% | -$4.61K | ﹤0.01% | 761 |
|
|
2021
Q2 | $25K | Hold |
365
| – | – | ﹤0.01% | 571 |
|
|
2021
Q1 | $21K | Hold |
365
| – | – | ﹤0.01% | 576 |
|
|
2020
Q4 | $30K | Hold |
365
| – | – | ﹤0.01% | 492 |
|
|
2020
Q3 | $26K | Hold |
365
| – | – | ﹤0.01% | 464 |
|
|
2020
Q2 | $30K | Hold |
365
| – | – | ﹤0.01% | 430 |
|
|
2020
Q1 | $21K | Hold |
365
| – | – | ﹤0.01% | 462 |
|
|
2019
Q4 | $38K | Buy |
365
+145
| +66% | +$15.1K | ﹤0.01% | 425 |
|
|
2019
Q3 | $4K | Hold |
220
| – | – | ﹤0.01% | 636 |
|
|
2019
Q2 | $6K | Buy |
+220
| New | +$6K | ﹤0.01% | 639 |
|